Alpharma Asks Appeals Court To Remove Stay On Neurontin Capsule Launch
Generics maker Alpharma Inc. has asked an appeals court to lift its order to stay the U.S. Food and Drug Administration's final approval of the company's generic version of Pfizer's epilepsy...To view the full article, register now.
Already a subscriber? Click here to view full article